These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24339137)

  • 21. Functional impacts of NRXN1 knockdown on neurodevelopment in stem cell models.
    Zeng L; Zhang P; Shi L; Yamamoto V; Lu W; Wang K
    PLoS One; 2013; 8(3):e59685. PubMed ID: 23536886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non Random Distribution of DMD Deletion Breakpoints and Implication of Double Strand Breaks Repair and Replication Error Repair Mechanisms.
    Marey I; Ben Yaou R; Deburgrave N; Vasson A; Nectoux J; Leturcq F; Eymard B; Laforet P; Behin A; Stojkovic T; Mayer M; Tiffreau V; Desguerre I; Boyer FC; Nadaj-Pakleza A; Ferrer X; Wahbi K; Becane HM; Claustres M; Chelly J; Cossee M
    J Neuromuscul Dis; 2016 May; 3(2):227-245. PubMed ID: 27854212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders.
    Voineskos AN; Lett TA; Lerch JP; Tiwari AK; Ameis SH; Rajji TK; Müller DJ; Mulsant BH; Kennedy JL
    PLoS One; 2011; 6(6):e20982. PubMed ID: 21687627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rare NRXN1 promoter variants in patients with schizophrenia.
    Shah AK; Tioleco NM; Nolan K; Locker J; Groh K; Villa C; Stopkova P; Pedrosa E; Lachman HM
    Neurosci Lett; 2010 May; 475(2):80-4. PubMed ID: 20347009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders.
    Ching MS; Shen Y; Tan WH; Jeste SS; Morrow EM; Chen X; Mukaddes NM; Yoo SY; Hanson E; Hundley R; Austin C; Becker RE; Berry GT; Driscoll K; Engle EC; Friedman S; Gusella JF; Hisama FM; Irons MB; Lafiosca T; LeClair E; Miller DT; Neessen M; Picker JD; Rappaport L; Rooney CM; Sarco DP; Stoler JM; Walsh CA; Wolff RR; Zhang T; Nasir RH; Wu BL;
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jun; 153B(4):937-47. PubMed ID: 20468056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microhomology-mediated mechanisms underlie non-recurrent disease-causing microdeletions of the FOXL2 gene or its regulatory domain.
    Verdin H; D'haene B; Beysen D; Novikova Y; Menten B; Sante T; Lapunzina P; Nevado J; Carvalho CM; Lupski JR; De Baere E
    PLoS Genet; 2013; 9(3):e1003358. PubMed ID: 23516377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fraternal twins with autism, severe cognitive deficit, and epilepsy: diagnostic role of chromosomal microarray analysis.
    Imitola J; Walleigh D; Anderson CE; Jethva R; Carvalho KS; Legido A; Khurana DS
    Semin Pediatr Neurol; 2014 Jun; 21(2):167-71. PubMed ID: 25149956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two rare deletions upstream of the NRXN1 gene (2p16.3) affecting the non-coding mRNA AK127244 segregate with diverse psychopathological phenotypes in a family.
    Duong LT; Hoeffding LK; Petersen KB; Knudsen CD; Thygesen JH; Klitten LL; Tommerup N; Ingason A; Werge T
    Eur J Med Genet; 2015 Dec; 58(12):650-3. PubMed ID: 26563496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia.
    Gauthier J; Siddiqui TJ; Huashan P; Yokomaku D; Hamdan FF; Champagne N; Lapointe M; Spiegelman D; Noreau A; Lafrenière RG; Fathalli F; Joober R; Krebs MO; DeLisi LE; Mottron L; Fombonne E; Michaud JL; Drapeau P; Carbonetto S; Craig AM; Rouleau GA
    Hum Genet; 2011 Oct; 130(4):563-73. PubMed ID: 21424692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.
    O'Dushlaine C; Kenny E; Heron E; Donohoe G; Gill M; Morris D; ; Corvin A
    Mol Psychiatry; 2011 Mar; 16(3):286-92. PubMed ID: 20157312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rare Copy Number Variants in NRXN1 and CNTN6 Increase Risk for Tourette Syndrome.
    Huang AY; Yu D; Davis LK; Sul JH; Tsetsos F; Ramensky V; Zelaya I; Ramos EM; Osiecki L; Chen JA; McGrath LM; Illmann C; Sandor P; Barr CL; Grados M; Singer HS; Nöthen MM; Hebebrand J; King RA; Dion Y; Rouleau G; Budman CL; Depienne C; Worbe Y; Hartmann A; Müller-Vahl KR; Stuhrmann M; Aschauer H; Stamenkovic M; Schloegelhofer M; Konstantinidis A; Lyon GJ; McMahon WM; Barta C; Tarnok Z; Nagy P; Batterson JR; Rizzo R; Cath DC; Wolanczyk T; Berlin C; Malaty IA; Okun MS; Woods DW; Rees E; Pato CN; Pato MT; Knowles JA; Posthuma D; Pauls DL; Cox NJ; Neale BM; Freimer NB; Paschou P; Mathews CA; Scharf JM; Coppola G; ;
    Neuron; 2017 Jun; 94(6):1101-1111.e7. PubMed ID: 28641109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single cell analysis of autism patient with bi-allelic NRXN1-alpha deletion reveals skewed fate choice in neural progenitors and impaired neuronal functionality.
    Lam M; Moslem M; Bryois J; Pronk RJ; Uhlin E; Ellström ID; Laan L; Olive J; Morse R; Rönnholm H; Louhivuori L; Korol SV; Dahl N; Uhlén P; Anderlid BM; Kele M; Sullivan PF; Falk A
    Exp Cell Res; 2019 Oct; 383(1):111469. PubMed ID: 31302032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NRXN1 deletion syndrome; phenotypic and penetrance data from 34 families.
    Al Shehhi M; Forman EB; Fitzgerald JE; McInerney V; Krawczyk J; Shen S; Betts DR; Ardle LM; Gorman KM; King MD; Green A; Gallagher L; Lynch SA
    Eur J Med Genet; 2019 Mar; 62(3):204-209. PubMed ID: 30031152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rare variants in the genetic background modulate cognitive and developmental phenotypes in individuals carrying disease-associated variants.
    Pizzo L; Jensen M; Polyak A; Rosenfeld JA; Mannik K; Krishnan A; McCready E; Pichon O; Le Caignec C; Van Dijck A; Pope K; Voorhoeve E; Yoon J; Stankiewicz P; Cheung SW; Pazuchanics D; Huber E; Kumar V; Kember RL; Mari F; Curró A; Castiglia L; Galesi O; Avola E; Mattina T; Fichera M; Mandarà L; Vincent M; Nizon M; Mercier S; Bénéteau C; Blesson S; Martin-Coignard D; Mosca-Boidron AL; Caberg JH; Bucan M; Zeesman S; Nowaczyk MJM; Lefebvre M; Faivre L; Callier P; Skinner C; Keren B; Perrine C; Prontera P; Marle N; Renieri A; Reymond A; Kooy RF; Isidor B; Schwartz C; Romano C; Sistermans E; Amor DJ; Andrieux J; Girirajan S
    Genet Med; 2019 Apr; 21(4):816-825. PubMed ID: 30190612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical relevance of intragenic
    Cosemans N; Vandenhove L; Vogels A; Devriendt K; Van Esch H; Van Buggenhout G; Olivié H; de Ravel T; Ortibus E; Legius E; Aerssens P; Breckpot J; R Vermeesch J; Shen S; Fitzgerald J; Gallagher L; Peeters H
    J Med Genet; 2020 May; 57(5):347-355. PubMed ID: 31932357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of speech and language phenotype in children with NRXN1 deletions.
    Brignell A; St John M; Boys A; Bruce A; Dinale C; Pigdon L; Hildebrand MS; Amor DJ; Morgan AT
    Am J Med Genet B Neuropsychiatr Genet; 2018 Dec; 177(8):700-708. PubMed ID: 30358070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes.
    Bucan M; Abrahams BS; Wang K; Glessner JT; Herman EI; Sonnenblick LI; Alvarez Retuerto AI; Imielinski M; Hadley D; Bradfield JP; Kim C; Gidaya NB; Lindquist I; Hutman T; Sigman M; Kustanovich V; Lajonchere CM; Singleton A; Kim J; Wassink TH; McMahon WM; Owley T; Sweeney JA; Coon H; Nurnberger JI; Li M; Cantor RM; Minshew NJ; Sutcliffe JS; Cook EH; Dawson G; Buxbaum JD; Grant SF; Schellenberg GD; Geschwind DH; Hakonarson H
    PLoS Genet; 2009 Jun; 5(6):e1000536. PubMed ID: 19557195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mini-review: Update on the genetics of schizophrenia.
    Coelewij L; Curtis D
    Ann Hum Genet; 2018 Sep; 82(5):239-243. PubMed ID: 29923609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prenatal diagnosis of partial deletion of NRXN1 gene with combined CNV-seq and qPCR assays].
    Wang L; Shi P; Ren H; Xue S; Kong X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Nov; 39(11):1200-1204. PubMed ID: 36317203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ionizing radiation and genetic risks. XVII. Formation mechanisms underlying naturally occurring DNA deletions in the human genome and their potential relevance for bridging the gap between induced DNA double-strand breaks and deletions in irradiated germ cells.
    Sankaranarayanan K; Taleei R; Rahmanian S; Nikjoo H
    Mutat Res; 2013; 753(2):114-130. PubMed ID: 23948232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.